NYSE:CORBF Global Cord Blood (CORBF) Stock Price, News & Analysis → They say it’s ‘unstoppable’ – How I made 43,509% (From Investing Daily) (Ad) Free CORBF Stock Alerts $1.25 0.00 (0.00%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$1.20▼$1.2550-Day Range$1.25▼$1.8552-Week Range$0.02▼$3.00Volume8,226 shsAverage Volume3,098 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsSocial Media Get Global Cord Blood alerts: Email Address Ad Investing DailyThey say it’s ‘unstoppable’ – How I made 43,509% Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.Click here now for the full story. About Global Cord Blood Stock (NYSE:CORBF)Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.Read More CORBF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CORBF Stock News HeadlinesApril 27, 2024 | bbc.comBangladesh's burgeoning pharmaceuticalsApril 27, 2024 | americanbankingnews.comFinancial Contrast: Sotera Health (NASDAQ:SHC) vs. Global Cord Blood (NYSE:CORBF)April 27, 2024 | Investing Daily (Ad)They say it’s ‘unstoppable’ – How I made 43,509% Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.April 25, 2024 | msn.comTherapeutic potential of human umbilical cord-derived mesenchymal stem cells in Crohn’s diseaseApril 25, 2024 | americanbankingnews.comBioRestorative Therapies (NASDAQ:BRTX) vs. Global Cord Blood (NYSE:CORBF) Head to Head ComparisonApril 9, 2024 | finanznachrichten.deDelveInsight Business Research, LLP: Global Tissue Banking Market to Exhibit Growth at a Considerable CAGR of ~6% by 2030, Assesses DelveInsightApril 9, 2024 | finance.yahoo.comGlobal Tissue Banking Market to Exhibit Growth at a Considerable CAGR of ~6% by 2030, Assesses DelveInsightApril 4, 2024 | msn.comScientists propose AI framework for mass-manufacturing of stem cells for regenerative medicineApril 27, 2024 | Investing Daily (Ad)They say it’s ‘unstoppable’ – How I made 43,509% Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.April 4, 2024 | msn.comGenetic variation may raise risk for obesity sixfoldApril 4, 2024 | msn.comExplained: What Are Mini-Strokes And How To Spot The Signs?April 3, 2024 | msn.comHormonal Birth Control Doesn’t Deserve Its Bad ReputationApril 2, 2024 | msn.comWhy Nairobi children are likely to be born with reduced intelligenceMarch 29, 2024 | sg.news.yahoo.comAuthentic Brands Names First Head of Australia, New ZealandMarch 28, 2024 | sg.finance.yahoo.comEDC's New Vietnam Representation Expands Trade Opportunities for Canadian CompaniesMarch 25, 2024 | finance.yahoo.comCryo-Cell Announces Plans to Explore Strategic Alternatives and Spin-off Celle Corp. to Maximize Shareholder ValueSee More Headlines Receive CORBF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Global Cord Blood and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/27/2024Fiscal Year End3/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Miscellaneous health & allied services, not elsewhere classified Sub-IndustryN/A Current SymbolNYSE:CORBF CUSIPN/A CIK1467808 Webwww.globalcordbloodcorp.com Phone852-3605-8180Fax852-3605-8181Employees1,202Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$196.12 million Price / SalesN/A Cash Flow$0.71 per share Price / Cash Flow1.75 Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable Beta-0.25 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMs. Ting Zheng (Age 52)CEO & CEO of Beijing Division Comp: $516.68kMr. Bing Chuen Chen (Age 48)Chief Financial Officer Comp: $516.68kMs. Xin Xu (Age 70)Chief Technology Officer Comp: $122.78kMs. Rui Arashiyama (Age 65)Chief Executive Officer of Guangdong & Zhejiang Divisions Comp: $257.5kMs. Cathy BaiVice President of Corporate FinanceKey Competitors180 Life SciencesNASDAQ:ATNFW60 Degrees PharmaceuticalsNASDAQ:SXTPWAclarionNASDAQ:ACONWAinosNASDAQ:AIMDWAlpha Tau MedicalNASDAQ:DRTSWView All Competitors CORBF Stock Analysis - Frequently Asked Questions How have CORBF shares performed in 2024? Global Cord Blood's stock was trading at $1.22 at the beginning of 2024. Since then, CORBF shares have increased by 2.5% and is now trading at $1.25. View the best growth stocks for 2024 here. How do I buy shares of Global Cord Blood? Shares of CORBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:CORBF) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThey say it’s ‘unstoppable’ – How I made 43,509% Investing DailyThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyProtect Your Bank Account Before It’s Too LateWeiss RatingsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global Cord Blood Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
